Home > Press > Curcumin Nanodrug Breaks Cancers' Resistance to Treatment
Abstract:
Researchers from Cancer Research Center of Tehran University of Medical Sciences produced biocompatible and biodegradable non-ionic polymeric nanocarriers that can be used in the targeted anticancer drug delivery.
The nanocarrier has been produced without using toxic catalysts and it has successfully passed clinical tests on a number of patients who suffered from cancer.
Studies show that curcumin – the active pharmaceutical ingredient in turmeric – has anticancer properties as well as having anti-oxidant and anti-inflammation characteristics, and it can prevent the cancer. However, when curcumin is consumed orally, very tiny amount of it is found in blood plasma or in target tissue. This fact can be caused because of the low amount of sorption, quick metabolism or quick elimination of curcumin from the body. Therefore, numerous methods have been developed to increase the amount of curcumin in plasma or in the target tissue.
According to the results of the research, encapsulation of curcumin in nano-emulsions (nano-curcumin) can increase therapeutic properties of the drug. Comprehensive studies carried out by the research team showed that nano-curcumin has much stronger effects on cancerous cells in cultivation media and in animal samples.
This nanodrug is tolerable without any toxicity in the first phase of clinical tests (investigation of its toxicity and the tolerable dosage) even in high dosages. At the moment, this nanodrug is in the end of the second phase of clinical test to treat digestion and breast cancers that resist treatment.
Results of the research have been published in BioMed Research International, vol. 2105, issue 824746, 2015, pp. 1-14.
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Cancer
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||